Velpatasvir
Velpatasvir is an NS5A inhibitor used only as part of a fixed combination for chronic hepatitis C. It is not a stand-alone antiviral.
Key points
- The complete combination and hepatitis C treatment plan determine suitability.
- Acid-reducing medicines can lower velpatasvir absorption and compromise treatment.
- Hepatitis B can reactivate during direct-acting antiviral treatment and requires screening and monitoring.
Listings are for comparison only; suitability and supply depend on specialist regimen review, interaction screening, prescription and pharmacy checks.
What velpatasvir is used for
Velpatasvir-containing combinations treat selected chronic hepatitis C across viral genotypes, with regimen details shaped by liver disease and prior treatment.
Important safety checks
Review hepatitis B status, liver and kidney disease, prior antiviral treatment and every medicine, especially acid reducers, amiodarone, anticonvulsants and herbal products.
When to seek urgent care
Seek urgent help for fainting or a very slow heartbeat, severe weakness, yellow skin or eyes, confusion, abdominal swelling, facial swelling or breathing difficulty.